# A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy

> **NCT01184599** · PHASE4 · UNKNOWN · sponsor: **Kagawa University** · enrollment: 30 (estimated)

## Conditions studied

- Glomerulonephritis, IGA
- Hypertension

## Interventions

- **DRUG:** aliskiren

## Key facts

- **NCT ID:** NCT01184599
- **Lead sponsor:** Kagawa University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-06
- **Primary completion:** 2013-03
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01184599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01184599, "A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01184599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*